Shrine Pharmaceuticals Private Limited
About Shrine Pharmaceuticals Private Limited
Data last updated:
Shrine Pharmaceuticals Private Limited is a private limited company based in Faridabad, Haryana, India. It operates in the household goods segment of the home appliances and consumer durables sector. It was incorporated on 16 November 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U51397HR2012PTC047683. Its GSTIN is 20AASCS5737R1ZJ (Jharkhand).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rakesh Kumar and Chandra Kishor Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No – 17/1 Gali No – 04 Nangla Enclave Part – II Subhash Chowk Nit., Faridabad, Haryana, India – 121005.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.15 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹23,703 (net margin 2.6%) and EBITDA of ₹32,031 (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 30% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Shrine Pharmaceuticals Private Limited's registered office is in Faridabad, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No – 17/1 Gali No – 04 Nangla Enclave Part – II Subhash Chowk Nit., Faridabad, Haryana, India – 121005
- IndustryHome Appliances, Household Goods, Wholesale
To see the full contact details of Shrine Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Shrine Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Shrine Pharmaceuticals Private Limited, buy the company report.
Financials of Shrine Pharmaceuticals Private Limited
FY 2025 filings availableShrine Pharmaceuticals Private Limited reported revenue of ₹9.15 Lakh (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 8% growth in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹32,031 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹23,703 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shrine Pharmaceuticals Private Limited, buy the company report.
Board of directors of Shrine Pharmaceuticals Private Limited
Shrine Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Kumar | Director | 16 Nov 2012 | 13 Years 11 Months | Current |
| Chandra Kishor Kumar | Director | 10 Aug 2018 | 8 Years 2 Months | Current |
Peer comparison
Shrine Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shrine Pharmaceuticals Private Limitedthis company | ₹9.15 Lakh (FY 2025) | ₹23,703 | 2.6% | 8.0% | Faridabad, Haryana, India | |
| Kingerly Pharmaceuticals Private Limited | ₹9.15 Lakh (FY 2023) | 610.0% | Nagpur, Maharashtra, India | |||
| Exevant Pharmaceuticals Private Limited | ₹9.12 Lakh (FY 2025) | 7.0% | Sikar, Rajasthan, India | |||
| Sigmavet Pharmaceuticals Private Limited | ₹9.11 Lakh (FY 2024) | Raebareilly, Uttar Pradesh, India |
To see the full peer comparison of Shrine Pharmaceuticals Private Limited, buy the company report.
Auditor
Shrine Pharmaceuticals Private Limited is audited by VERMA D . K & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VERMA D . K & CO. | FY 2017 | 011669C |
Shareholding
The shareholding of Shrine Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Shrine Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Shrine Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shrine Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Shrine Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AASCS5737R1ZJ | Jharkhand | Active | 14 May 2019 |
To see the full GST registrations and return filing status of Shrine Pharmaceuticals Private Limited, buy the company report.
Recent activity
Shrine Pharmaceuticals Private Limited has 4 board changes on record since 2012: 3 appointments and 1 cessation. The latest: Umesh Kumar Singh ceased to be Director on 15 Jan 2019.
Frequently asked questions
Shrine Pharmaceuticals is an active private limited company based in Faridabad, Haryana, India. The company works in household goods, within the home appliances industry. It was incorporated on 16 November 2012 (14+ years old) and is registered under CIN U51397HR2012PTC047683.
Shrine Pharmaceuticals has 2 current directors:
- Rakesh Kumar - Director
- Chandra Kishor Kumar - Director
The latest financial statements of Shrine Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Shrine Pharmaceuticals is 20AASCS5737R1ZJ, registered in Jharkhand.
The CIN (Corporate Identification Number) of Shrine Pharmaceuticals is U51397HR2012PTC047683. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shrine Pharmaceuticals was incorporated on 16 November 2012, making it 14+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Shrine Pharmaceuticals by revenue are Kingerly Pharmaceuticals Private Limited, Exevant Pharmaceuticals Private Limited, Sigmavet Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Umesh Kumar Singh ceased to be Director on 15 Jan 2019. Chandra Kishor Kumar was appointed as Director on 10 Aug 2018. Rakesh Kumar was appointed as Director on 10 Aug 2018. Shrine Pharmaceuticals has 4 board changes on record in total.
The registered office of Shrine Pharmaceuticals is at House No – 171 Gali No – 04 Nangla Enclave Part – II Subhash Chowk Nit., Faridabad, Haryana, India – 121005.
Shrine Pharmaceuticals operates in the home appliances industry, in the household goods segment.
The compliance status of Shrine Pharmaceuticals is compliant as of 16 July 2026. The company is actively filing with the Registrar of Companies.